Son İki Yılda Uluslararası Dergilerde Yayınlanan Makaleler
2024
20. Tezcan, D.; Eryavuz onmaz, D.; Körez, M.; Limon, M.; Gülcemal, S.; Yılmaz, S.; Sivrikaya, A. The role of fatty acids in patients with Behçets disease and their association with thrombosis. LIPIDS, 2024, , 1-11.
10.1002/lipd.12398
19. Limon, M. Kartagener's syndrome and undifferentiated connective tissue
disease. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASE, 2024, 27, 1-3.
10.1111/1756-185X.15179
18. özdoğan, O.; Altıntaş, E.; Kasap, E.; Sezgin, O.; Oğuz, D.; Yaraş, S. Turkish Society of Gastroenterology: Pancreas Working Group, Acute Pancreatitis Committee Consensus Report. TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35, 1-44.
10.5152/tjg.2024.24392
17. Yildirim, N.; Balcı, .; Tamer, L. Reduced Expression of miRNAs as Potential Biomarkers in Axial Spondyloarthritis. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70, 1-6.
10.1590/1806-9282.20231521
16. Güngör semiz, G.; Demir, T.; Yıldırım şimşir, I.; Selimoğlu, .; Yılmaz, M.; Elidokuz, H.; Onay, H.; Gen, R.; Evren, B. Evaluation of Coronavirus Disease 2019-Related Morbidity and Mortality in Lipodystrophy Patients During the Pandemic Period. ENDOCRINOLOGY RESEARCH AND PRACTICE, 2024, 28, 151-155.
10.5152/erp.2024.23352
15. Köşeci, T.; Seyyar, M.; Aydınalp, Y.; çelik, H.; Mete, B.; Demirhindi, H.; Ata, S.; Solmaz, A.; çil, T. HALP Score in Predicting Response to Treatment in Patients with Early-Stage Gastric Cancer: A Multi-Centred Retrospective Cohort Study. MEDICINA, 2024, 60, 2087-2098.
10.3390/medicina60122087
14. özdoğan, O.; Altıntaş, E.; Kasap, E.; Sezgin, O.; Oğuz, D.; Soytürk, M.; Bengi, G. Prevalence of Pancreatic Steatosis and Its Associated Factors in Turkey: A Nation-Wide Multicenter Study. TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35, 239-254.
10.5152/tjg.2024.23583
13. çerçi koçar, .; özcan, P.; Koç, Z.; Süle, M.; Akbay, E.; Gen, R.; Sezer, K. Retrospective analysis of thyroid incidentalomas detected by [68Ga]
Ga-PSMA-11 PET/CT. ENDOCRINE, 2024, 86, 302-309.
10.1007/s12020-024-03847-8
12. Aytan, P.; Gökulu, .; Durukan, H.; Bozkurt, S.; Taşın, C.; Aslan, E.; Aytan, H. A New Marker for the Diagnosis of Acute Pelvic Inflammatory Disease: Immature Granulocyte. CLINICAL LABORATORY, 2024, 70, 517-524.
10.7754/Clin.Lab.2023.230807
11. Kırmızıer, G.; Altunel kılınç, E.; Yildirim, N. Successful treatment of PASS syndrome with IVIG and anti‐IL‐1 treatment: A case report. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27, -5.
10.1111/1756-185X.15114
10. Balcı fidancı, .; Yildirim, N.; Derici yıldırım, D.; Eroğlan, .; Bölgen çimen, .; Tamer, L.; çimen, M. The role of circulating miRNAs in the diagnosis of osteoporosis miRNAs in osteoporosis. REVISTA DA ASSOCIAÇãO MéDICA BRASILEIRA, 2024, 70, -6.
10.1590/1806-9282.20231724
9. Turgutalp, K. Biopsy-proven BK virus nephropathy in renal transplant recipients: A multi-central study from Turkey (BK-TURK STUDY). CLINICAL NEPHROLOGY, 2024, 102, -.
10.5414/CN111300
8. Turgutalp, K. Patients with crush syndrome and kidney disease: lessons learned from the earthquake in Kahramanmaraş, Türkiye. KIDNEY INTERNATIONAL, 2024, 106, -.
10.1016/j.kint.2024.08.008
7. Koç, Z.; özcan, P.; Balcı, Y.; Sayar, H.; Turgutalp, K. Incidental finding of diffuse Tc-99m methylene diphosphonate uptake in lungs in a patient with renal insufficiency and lymphoma. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20, -.
10.4103/jcrt.jcrt_346_22
6. Turgutalp, K. Observational study of immunosuppressive treatment patterns and outcomes in primary membranous nephropathy: a multicenter retrospective analysis. BMC NEPHROLOGY, 2024, 25, -.
10.1186/s12882-024-03784-8
5. Yaraş, S. Prevalence of Pancreatic Steatosis and Its Associated Factors in Turkey: A Nation-Wide Multicenter Study. TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35, -.
10.5152/tjg.2024.23583
4. Turgutalp, K. Epidemiological analysis of the victıms wıth crush syndrome in earthquakes of southeastern Turkey. JOURNAL OF NEPHROLOGY, 2024, 37, -.
10.1007/s40620-024-02051-1
3. Altıntaş, E. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohns disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study. THE LANCET, 2024, 404, -.
10.1016/S0140-6736(24)01762-8
2. Oruç, A.; şumnu, A.; Türkmen, A.; Baştürk, T.; Cebeci, E.; Turgutalp, K.; Seyahi, N.; Tatar, E.; Derici, . Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group. RENAL FAILURE, 2024, 46, -.
10.1080/0886022X.2024.2341787
1. Turgutalp, K. Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?. JOURNAL OF NEPHROLOGY, 2024, , -.
10.1007/s40620-023-01770-1
